Probiotics for infantile colic: a systematic review
Open Access
- 15 November 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Pediatrics
- Vol. 13 (1), 186
- https://doi.org/10.1186/1471-2431-13-186
Abstract
Infantile colic is a common paediatric condition which causes significant parental distress. Increased intestinal coliform colonization in addition to alteration in Lactobacillus abundance and distribution may play an important role in its pathogenesis. The objectives of this systematic review are to evaluate the efficacy of probiotic supplementation in the reduction of crying time and successful treatment of infantile colic. Literature searches were conducted of MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials. Only randomized controlled trials enrolling term, healthy infants with colic were included. A meta-analysis of included trials was performed utilizing the Cochrane Collaboration methodology. Three trials that enrolled 220 breastfed infants met inclusion criteria, of which 209 infants were available for analysis. Two of the studies were assessed as good quality. Lactobacillus reuteri (strains-American Type Culture Collection Strain 55730 and DSM 17 938) was the only species utilized in the therapeutic intervention. Two of the trials were industry funded. Probiotic supplementation compared to simethicone or placebo significantly and progressively shortened crying times to 7 days reaching a plateau at three weeks post initiation of therapy [mean difference −56.03 minutes; 95% CI (−59.92, -52.15)]. Similarly, probiotics compared to placebo significantly increased the treatment success of infantile colic with a relative risk (RR) of 0.06; 95% CI (0.01, 0.25) and a number needed to treat of 2. Although L. reuteri may be effective as a treatment strategy for crying in exclusively breastfed infants with colic, the evidence supporting probiotic use for the treatment of infant colic or crying in formula-fed infants remains unresolved. Results from larger rigorously designed studies will help draw more definitive conclusions.Keywords
This publication has 37 references indexed in Scilit:
- Probiotics to improve outcomes of colic in the community: Protocol for the Baby Biotics randomised controlled trialBMC Pediatrics, 2012
- Promoting Transparency in Pharmaceutical Industry–Sponsored ResearchAmerican Journal of Public Health, 2012
- Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infantsBMC Microbiology, 2011
- Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Altered Fecal Microflora and Increased Fecal Calprotectin in Infants with ColicThe Journal of Pediatrics, 2009
- Removal of Antibiotic Resistance Gene-Carrying Plasmids from Lactobacillus reuteri ATCC 55730 and Characterization of the Resulting Daughter Strain, L . reuteri DSM 17938Applied and Environmental Microbiology, 2008
- Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogensAnaerobe, 2008
- Mothers' postpartum psychological adjustment and infantile colicArchives of Disease in Childhood, 2006
- Bacterial counts of intestinal Lactobacillus species in infants with colicPediatric Allergy and Immunology, 2005
- Systematic review of the occurrence of infantile colic in the communityArchives of Disease in Childhood, 2001